As expected, the European Commision approves Merck's (MRK) Keytruda (pembrolizumab), combined with carboplatin and Celgene's (CELG) Abraxane (paclitaxel pr
Ex-dividend dates are important to dividend investors because one must own a stock on its ex-dividend date in order to be eligible to receive its next dividend.
AstraZeneca plc.’s (NYSE:AZN) stock has rallied 11.9% this year so far, outperforming the industry’s rise of 3.7%.The company’s outperformance has been backed...
For Immediate ReleaseChicago, IL –March 18, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts...
Merck & Co., Inc. (NYSE:MRK) announced that the European Medicines Agency (“EMA”) has approved the label expansion of its blockbuster PD-1 inhibitor, Keytruda...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Strong Sell||Strong Sell||Sell||Buy||Buy|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Buy||Strong Buy|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Buy||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Engulfing Bearish||1W||2||Mar 03, 2019|
|Tri-Star Bullish||1H||2||Mar 18, 2019 07:00AM|
|Dark Cloud Cover||1M||3||Dec 18|
|Tri-Star Bullish||30||4||Mar 18, 2019 07:30AM|
|Tri-Star Bullish||15||4||Mar 18, 2019 07:45AM|
|X Financial A||6.1800||6.3500||5.4500||+0.7300||+13.39%||42.76K||15:59:59|
|Petroleo Brasileiro Petrobras ADR||17.11||17.11||16.60||+0.52||+3.13%||22.90M||15:59:59|
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.Read More
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.